ARCA biopharma competitors

ARCA biopharma's competitors include CRISPR Therapeutics, Aevi Genomic Medicine, Sarepta Therapeutics and Ultragenyx Pharmaceutical
Add company...
ARCA biopharma
ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
CRISPR Therapeutics
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Aevi Genomic Medicine
Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Founding Date
Founding Date
2009
Founding Date
2013
Founding Date
2000
Founding Date
1980
Founding Date
2010
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Westminster, US HQ
Aurora, US
Westminster, US
Locations
Zug, CH HQ
Greater London, GB
Cambridge, US
Locations
Wayne, US HQ
San Francisco, US
Locations
Cambridge, US HQ
Locations
Novato, US HQ
Employees
Employees
20
Employees
93
Employees
24
Employees
197
Employees
376
Valuation ($)
Valuation ($)
8.4 m
Valuation ($)
2.4 b
Valuation ($)
66.5 m
Valuation ($)
8.6 b
Valuation ($)
3.9 b
Twitter followers
Twitter followers
N/A
Twitter followers
3.5 k
Twitter followers
N/A
Twitter followers
302
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$154.6m (FY, 2017)
Revenue (est.)
$133k (FY, 2016)
Net income
Net income
($18.5m) (FY, 2017)
Net income
($68.4m) (FY, 2017)
Net income
($34.7m) (FY, 2017)
Net income
($50.7m) (FY, 2017)
Net income
($245.9m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 7.2m
Total funding raised
$ 127m
Total funding raised
$ 7m
Total funding raised
N/A
Total funding raised
$ 200.1m
For sources of this data, please see the company profileDownload Excel

View company profiles

CRISPR Therapeutics
HQ
Zug, CH
Employees
93

CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.

View company
Aevi Genomic Medicine
HQ
Wayne, US
Employees
24

Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.

View company
Sarepta Therapeutics
HQ
Cambridge, US
Employees
197

Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.

View company
Ultragenyx Pharmaceutical
HQ
Novato, US
Employees
376

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

View company